Women and peripheral arterial disease: Same disease, different issues

Journal of Cardiovascular Medicine

Volumn 9, Issue 4, 2008, Pages 382-388

  Brevetti, Gregorio ^a,d   Bucur, Roxana ^a   Balbarini, Alberto ^b   Melillo, Elio ^b   Novo, Salvatore ^c   Muratori, Ida ^c   Chiariello, Massimo ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c UNIVERSITY OF PALERMO   (Italy)

^d NONE   (Italy)

Author keywords

Critical limb ischemia; Gender; Intermittent claudication; Peripheral arterial disease

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ARTERY DISEASE; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; COMORBIDITY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; INFLAMMATION; INTERMITTENT CLAUDICATION; LIMB ISCHEMIA; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PROGNOSIS; QUALITY OF LIFE; REVASCULARIZATION; RISK FACTOR; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; SYMPTOM;

ATHEROSCLEROSIS; CHI-SQUARE DISTRIBUTION; COMORBIDITY; FEMALE; HUMANS; INFLAMMATION; ITALY; LEG; LOGISTIC MODELS; MALE; PERIPHERAL VASCULAR DISEASES; PREVALENCE; QUALITY OF LIFE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; STATISTICS, NONPARAMETRIC;

EID: 40649119718     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/JCM.0b013e3282f03b90     Document Type: Article

References (31)

1. DeVon HA, Zerwic JJ. Symptoms of acute coronary syndromes: are there gender differences? A review of the literature. Heart Lung 2002; 31:235-245.
2. Leopold JA, Jacobs AK. Catheter-based revascularization strategies for acute coronary syndromes in women. Rev Cardiovasc Med 2001; 2:181-189.
3. Hochman JS, Tamis-Holland JE. Acute coronary syndromes: does sex matter? JAMA 2002; 288:3161-3164.
4. Newman AB, Siscovick DS, Manolio TA, Polak J, Fried LP, Borhani NO, et al. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group. Circulation 1993; 88:837-845.
5. Criqui MH, Fronek A, Barrett-Connor E, Klauber MR, Gabriel S, Goodman D. The prevalence of peripheral arterial disease in a defined population. Circulation 1985; 71:510-515.
6. Eberhardt RT, Coffman JD. Cardiovascular morbidity and mortality in peripheral arterial disease. Curr Drug Targets Cardiovasc Haematol Disord 2004; 4:209-217.
7. Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR, McCann TJ, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992; 326:381-386.
8. Newman AB, Shemanski L, Manolio TA, Cushman M, Mittelmark M, Polak JF, et al. Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group. Arterioscler Thromb Vasc Biol 1999; 19:538-545.
9. Silvestro A, Bacchieri A, Bucur R, Di Donato AM, Costantino C, Corrado S, et al. Un nuovo questionario per la valutazione della qualità della vita nel paziente affetto da claudicatio intermittens. Minerva Cardioangiol 2000; 48:455-465.
10. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M, et al. Centers for Disease Control and Prevention; American Heart Association. Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003; 107:499-511.
11. Fronek A, Coel M, Berstein EF. Quantitative ultrasonographic studies of lower extremity flow velocities in health and disease. Circulation 1976; 53:957-960.
12. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
13. Roddy SP, Darling RC 3rd, Maharaj D, Chang BB, Paty PS, Kreienberg PB, et al. Gender-related differences in outcome: an analysis of 5880 infrainguinal arterial reconstructions. J Vasc Surg 2003; 37:399-402.
14. Eugster T, Gurke L, Obeid T, Stierli P. Infrainguinal arterial reconstruction: female gender as risk factor for outcome. Eur J Vasc Endovasc Surg 2002; 24:245-248.
15. Belkin M, Conte MS, Donaldson MC, Mannick JA, Whittemore AD. The impact of gender on the results of arterial bypass with in situ greater saphenous vein. Am J Surg 1995; 170:97-102.
16. Gardner AW. Sex differences in claudication pain in subjects with peripheral arterial disease. Med Sci Sports Exerc 2002; 34:1695-1698.
17. McDermott MM, Greenland P, Liu K, Criqui MH, Guralnik JM, Celic L, et al. Sex differences in peripheral arterial disease: leg symptoms and physical functioning. J Am Geriatr Soc 2003; 51:222-228.
18. Neri Serneri GG, Coccheri S, Marubini E, Violi F, Drug Evaluation in Atherosclerotic Vascular Disease in Diabetics (DAVID) Study Group. Picotamide, a combined inhibitor of thromboxane A2 synthase and receptor, reduces 2-year mortality in diabetics with peripheral arterial disease: the DAVID study. Eur Heart J 2004; 25:1845-1852.
19. Brevetti G, Diehm C, Lambert D. European multicenter study on propionyl-L-carnitine in intermittent claudication. J Am Coll Cardiol 1999; 34:1618-1624.
20. Lievre M, Morand S, Besse B, Fiessinger JN, Boissel JP. Oral Beraprost sodium, a prostaglandin I(2) analogue, for intermittent claudication: a double-blind, randomized, multicenter controlled trial. Beraprost et Claudication Intermittente (BERCI) Research Group. Circulation 2000; 102:426-431.
21. Novo S, Coppola G, Milio G. Critical limb ischemia: definition and natural history. Curr Drug Targets Cardiovasc Haematol Disord 2004; 4:219-225.
22. AhChong AK, Chiu KM, Wong M, Yip AW. The influence of gender differences on the outcomes of infrainguinal bypass for critical limb ischemia in Chinese patients. Eur J Vasc Endovasc Surg 2002; 35:510-516.
23. Stangl V, Baumann G, Stangl K. Coronary atherogenic risk factors in women. Eur Heart J 2002; 23:1738-1752.
24. Gorter PM, Olijhoek JK, van der Graaf Y, Algra A, Rabelink TJ, Visseren FL, SMART Study Group. Prevalence of the metabolic syndrome in patients with coronary heart disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm. Atherosclerosis 2004; 173:363-369.
25. Brevetti G, Schiano V, Sirico G, Giugliano G, Laurenzano E, Chiariello M. Metabolic syndrome in peripheral arterial disease: relationship with severity of peripheral circulatory insufficiency, inflammatory status, and cardiovascular comorbidity. J Vasc Surg 2006; 44:101-107.
26. Eberly LE, Prineas R, Cohen JD, Vazquez G, Zhi X, Neaton JD, et al., Multiple Risk Factor Intervention Trial Research Group. Metabolic syndrome: risk factor distribution and 18-year mortality in the multiple risk factor intervention trial. Diabetes Care 2006; 29:123-130.
27. Khera A, McGuire DK, Murphy SA, Stanek HG, Das SR, Vongpatanasin W, et al. Race and gender differences in C-reactive protein levels. J Am Coll Cardiol 2005; 46:464-469.
28. Garcia-Moll X, Zouridakis E, Cole D, Kaski JC. C-reactive protein in patients with chronic stable angina: differences in baseline serum concentration between women and men. Eur Heart J 2000; 21:1598-1606.
29. Skerret PJ, Spelsberg A, Manson JE. Carbohydrate metabolism, obesity, and diabetes mellitus. In: Douglas PS, editor. Cardiovascular health and disease in women. 2nd ed. Philadelphia: WB Saunders; 2002. pp. 39-70.
30. Pearson TA, Blair SN, Daniels SR, Eckel RH, Fair JM, Fortmann SP, et al. AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation 2002; 106:388-391.
31. Collins TC, Suarez-Almazor M, Bush RL, Petersen NJ. Gender and peripheral arterial disease. J Am Board Fam Med 2006; 19:132-140.